MARKET

CATX

CATX

Perspective Therapeutics Inc
AMEX
3.900
-0.100
-2.50%
After Hours: 3.900 0 0.00% 16:24 07/15 EDT
OPEN
3.960
PREV CLOSE
4.000
HIGH
4.188
LOW
3.750
VOLUME
1.70M
TURNOVER
--
52 WEEK HIGH
16.55
52 WEEK LOW
1.600
MARKET CAP
289.49M
P/E (TTM)
-3.2282
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CATX last week (0707-0711)?
Weekly Report · 1d ago
Perspective Therapeutics (CATX) Receives a Buy from Scotiabank
TipRanks · 5d ago
Weekly Report: what happened at CATX last week (0630-0704)?
Weekly Report · 07/07 09:38
Perspective Therapeutics Updates Strategic Focus on Radiopharmaceuticals
TipRanks · 07/03 12:28
Perspective Therapeutics management to meet with Piper Sandler
TipRanks · 07/02 13:30
Weekly Report: what happened at CATX last week (0623-0627)?
Weekly Report · 06/30 09:40
Buy Rating for Perspective Therapeutics: Clinical Advancements and Strategic Developments Drive Positive Outlook
TipRanks · 06/25 14:35
Perspective Therapeutics Advances Phase 1/2a Clinical Trial
TipRanks · 06/23 18:23
More
About CATX
Perspective Therapeutics, Inc. is a radiopharmaceutical development company that is developing advanced treatment applications for cancers throughout the body. The Company has proprietary technology that utilizes the alpha-emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties. It is also developing imaging diagnostics that incorporate the same targeting moieties, which provide the opportunity to personalize treatment and optimize patient outcomes. This theranostic approach enables the ability to see the specific tumor and then treat it to potentially improve efficacy and minimize toxicity. The Company's melanoma (VMT01) and neuroendocrine tumor (VMT-a-NET) programs have entered Phase I/IIa imaging and therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at several academic institutions. It has also developed a 212Pb generator to secure key isotopes for clinical trial and commercial operations.

Webull offers Perspective Therapeutics Inc stock information, including AMEX: CATX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CATX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CATX stock methods without spending real money on the virtual paper trading platform.